New treatments can enable children born with HIV to live well into their adult years, but the antiretroviral therapy (ART) can cause high cholesterol. Researchers are urging early cholesterol monitoring for these kids.

A new study suggests there isn't enough evidence to recommend the widespread use of cholesterol-lowering stain drugs for patients who don't have a history of cardiovascular disease.